This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tsushima, T. Articles by Hashimoto, Y. Search for Related Content PubMed PubMed Citation Articles by Tsushima, T. Articles by Hashimoto, Y.

Serum Concentration of 20K Human Growth Hormone (20K hGH) Measured by a Specific Enzyme-Linked Immunosorbent Assay¹

Department of Medicine 2, Tokyo Women’s Medical University (T.T.), Tokyo 162-8666; Department of Medicine 1, Shimane Medical School (Y.K.), Izumo 693-8501; First Department of Medicine, Tokyo 143-8541 University School of Medicine (Y.M.), Tokyo 143-8541; Department of Internal Medicine 3, Kobe University School of Medicine (K.C.), Kobe 650-0017; Department of Neurosurgery, Nippon Medical School (A.T.), Tokyo 113-8603; Toho Medical School (M.I.), Tokyo 143-8541; and Institute of Biological Science, Mitsui Pharmaceuticals, Inc. (Y.H.), Mobara 297-0017, Japan

Address all correspondence and requests for reprints to: Dr. Toshio Tsushima, Department of Medicine, Tokyo Women’s Medical University, Kawadacho 8–1, Shinjukuku, Tokyo 162-8666, Japan. E-mail: tsushimt{at}ss.iij4u.or.jp

Several GH isoforms have been identified in pituitary and serum, the most abundant of which is the 22K human GH (hGH) isoform. The 20K hGH isoform is produced by alternative splicing of GH messenger ribonucleic acid and comprises approximately 10% of all GH in the pituitary. The physiological role of 20K hGH remains to be determined, partly because of the lack of a simple and specific assay. We have established sensitive enzyme-linked immunosorbent assays (ELISAs) specific to 20K and 22K hGH. To determine whether regulation of 20K hGH secretion is the same as that for 22K hGH, we measured serum concentrations of both species of hGH in normal subjects and patients with a variety of endocrine disorders. The serum levels of 20K hGH after overnight fasting was 118 ± 178 pg/mL (n = 282) in normal women, significantly higher than that in normal men (64 ± 170 pg/mL; n = 226). However, there was no difference in the proportion of 20K hGH to 20K plus 22K hGH between men (6.3 ± 2.6%, mean ± SD; n = 176) and women (6.3 ± 2.1%; n = 263). No correlation was detected between the ratio of 20K hGH and age, body height, body weight, or body fat mass in normal subjects. The proportion of 20K hGH was significantly (P < 0.001) higher in patients with active acromegaly (9.2 ± 2.2%; n = 33) and patients with anorexia nervosa (9.0 ± 1.9; n = 8), both of which are characterized by chronic elevation of circulating GH levels. The proportion of 20K hGH in successfully treated acromegalic patients did not differ from that in normal subjects, suggesting that GH-producing pituitary tumors secrete a higher proportion of 20K hGH, or that a chronic excess of 22K hGH alters the MCR of 20K hGH. The values in patients with adult GH deficiency, hyperthyroidism, primary hypothyroidism, or GH-independent short stature did not differ from those in normal subjects. The 20K ratio did not change after acute GH provocative tests, such as the insulin tolerance test and the GHRH test. These results suggest that secretion of 20K hGH from the pituitary is under the same control as that of 22K hGH. This new assay may provide a tool for understanding the physiological or pathophysiological role of the 20K hGH isoform.

This article has been cited by other articles:

				A. E. Nelson, C. J. Howe, T. V. Nguyen, K.-C. Leung, G. J. Trout, M. J. Seibel, R. C. Baxter, D. J. Handelsman, R. Kazlauskas, and K. K. Ho Influence of Demographic Factors and Sport Type on Growth Hormone-Responsive Markers in Elite Athletes J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4424 - 4432. [Abstract] [Full Text] [PDF]

				M. Hayakawa, Y. Shimazaki, T. Tsushima, Y. Kato, K. Takano, K. Chihara, A. Shimatsu, and M. Irie Metabolic Effects of 20-Kilodalton Human Growth Hormone (20K-hGH) for Adults with Growth Hormone Deficiency: Results of an Exploratory Uncontrolled Multicenter Clinical Trial of 20K-hGH J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1562 - 1571. [Abstract] [Full Text] [PDF]

				K.-C. Leung, C. Howe, L. Y.-Y. Gui, G. Trout, J. D. Veldhuis, and K. K. Y. Ho Physiological and pharmacological regulation of 20-kDa growth hormone Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E836 - E843. [Abstract] [Full Text] [PDF]

				J. D. Wallace, R. C. Cuneo, M. Bidlingmaier, P. A. Lundberg, L. Carlsson, C. L. Boguszewski, J. Hay, M. Boroujerdi, A. Cittadini, R. Dall, et al. Changes in Non-22-Kilodalton (kDa) Isoforms of Growth Hormone (GH) after Administration of 22-kDa Recombinant Human GH in Trained Adult Males J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1731 - 1737. [Abstract] [Full Text]

				J. D. Wallace, R. C. Cuneo, M. Bidlingmaier, P. A. Lundberg, L. Carlsson, C. L. Boguszewski, J. Hay, M.-L. Healy, R. Napoli, R. Dall, et al. The Response of Molecular Isoforms of Growth Hormone to Acute Exercise in Trained Adult Males J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 200 - 206. [Abstract] [Full Text]

				Y. Hashimoto, T. Kamioka, M. Hosaka, K. Mabuchi, A. Mizuchi, Y. Shimazaki, M. Tsunoo, and T. Tanaka Exogenous 20K Growth Hormone (GH) Suppresses Endogenous 22K GH Secretion in Normal Men J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 601 - 606. [Abstract] [Full Text]

				B. Tsunekawa, M. Wada, M. Ikeda, S. Banba, H. Kamachi, E. Tanaka, and M. Honjo The Binding between the Stem Regions of Human Growth Hormone (GH) Receptor Compensates for the Weaker Site 1 Binding of 20-kDa Human GH (hGH) than That of 22-kDa hGH J. Biol. Chem., May 19, 2000; 275(21): 15652 - 15656. [Abstract] [Full Text] [PDF]